Data gathered: November 27
AI Stock Analysis - Sana Biotechnology (SANA)
Analysis generated August 13, 2024. Powered by Chat GPT.
Sana Biotechnology is a biotechnology company specializing in creating and delivering engineered cells as a medication for patients. The company is at the cutting edge of the biotechnology industry, focusing on developing platforms intending to repair and control genes in cells and establish specific cell types to combat different diseases. The company’s ambitious goals are matched by its innovative approaches and significant investments in research and development.
Stock Alerts - Sana Biotechnology (SANA)
 |
Sana Biotechnology | November 27 Price is up by 5.3% in the last 24h. |
|
Sana Biotechnology | November 25 Price is down by -5.2% in the last 24h. |
|
Sana Biotechnology | November 22 Price is up by 6% in the last 24h. |
|
Sana Biotechnology | November 21 Price is down by -5.1% in the last 24h. |
Alternative Data for Sana Biotechnology
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 8 | Sign up | Sign up | Sign up |
| Sentiment | 57 | Sign up | Sign up | Sign up |
| Webpage traffic | 24,000 | Sign up | Sign up | Sign up |
| Employee Rating | 56 | Sign up | Sign up | Sign up |
| Google Trends | 21 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,077 | Sign up | Sign up | Sign up |
| Twitter Mentions | 12 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 18 | Sign up | Sign up | Sign up |
| Linkedin Employees | 365 | Sign up | Sign up | Sign up |
About Sana Biotechnology
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines.
| Price | $2.55 |
| Target Price | Sign up |
| Volume | 812,240 |
| Market Cap | $554M |
| Year Range | $2.34 - $10.44 |
| Dividend Yield | 0% |
| Analyst Rating | 57% buy |
| Industry | Biotechnology |
In the news
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANANovember 25 - Finnhub |
|
Sana Biotechnology to Present at December 2024 Investor ConferencesNovember 25 - Finnhub |
|
Sana Biotechnology : Amendment to Initial Statement of Beneficial Ownership - Form 3/ANovember 20 - Finnhub |
|
 |
Sana Biotechnology: The Story Becomes MurkierNovember 19 - SeekingAlpha |
 |
HC Wainwright Reaffirms “Buy” Rating for Sana Biotechnology (NASDAQ:SANA)November 13 - ETF Daily News |
 |
Here's Why Sana (SANA) Could be Great Choice for a Bottom FisherNovember 12 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 0 | 14M | -14M | -60M | -62M | 0.000 |
| Q2 '24 | 0 | 16M | -16M | -50M | -49M | -0.320 |
| Q1 '24 | 0 | 16M | -16M | -107M | -102M | -0.320 |
| Q4 '23 | 0 | 21M | -21M | -88M | -69M | -0.410 |
| Q3 '23 | 0 | 19M | -19M | 980,000 | 2.3M | 0.020 |
Insider Transactions View All
| Mulligan Richard filed to sell 2,698,121 shares at $3.9. September 26 '24 |
| Yang Patrick Y filed to sell 149,250 shares at $9.5. March 11 '24 |
| AFEYAN NOUBAR filed to buy 2,727,272 shares at $5.5. February 14 '24 |
| ARCH Venture Fund IX, L.P. filed to buy 10,667,387 shares at $5.5. February 12 '24 |
| ARCH Venture Fund IX, L.P. filed to buy 12,446,022 shares at $5.5. February 12 '24 |
Similar companies
Read more about Sana Biotechnology (SANA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Sana Biotechnology?
The Market Cap of Sana Biotechnology is $554M.
What is the current stock price of Sana Biotechnology?
Currently, the price of one share of Sana Biotechnology stock is $2.55.
How can I analyze the SANA stock price chart for investment decisions?
The SANA stock price chart above provides a comprehensive visual representation of Sana Biotechnology's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Sana Biotechnology shares. Our platform offers an up-to-date SANA stock price chart, along with technical data analysis and alternative data insights.
Does SANA offer dividends to its shareholders?
As of our latest update, Sana Biotechnology (SANA) does not offer dividends to its shareholders. Investors interested in Sana Biotechnology should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Sana Biotechnology?
Some of the similar stocks of Sana Biotechnology are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.